Acne Medication Market 2023 | Industry Size USD 13.35 billion by 2027 | CAGR of 3.8%

After the pandemic worsened the global scenario, a number of dermatology clinics were made to close their services, owing to curb the spread. Also, several hospitals and clinics have been transformed into COVID-19 centers.
By: AMR
 
PUNE, India - Dec. 21, 2022 - PRLog -- According to the report published by Allied Market Research, Increase in prevalence of acne diseases, surge in focus toward good quality skincare products, and unhealthy urban lifestyle drive the growth of the global Acne Medication Market. However, the side-effects associated with acne medications and the availability of alternatives for acne treatment hamper the market growth. On the contrary, increased R&D to lessen the side effects would open new opportunities for the market players in the future.

The Global Acne Medication Market Size was valued at USD 11.86 billion in 2019 and is poised to reach USD 13.35 billion by 2027, witnessing a Growing CAGR of 3.8% from 2020 to 2027.

Acne Medication Companies
  • Bausch Health Companies Inc.
  • GlaxoSmithKline Plc (GSK)
  • Galderma S.A
  • Mayne Pharma Group Limited
  • Almirall SA.
  • Pfizer Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/4356

On the basis of formulation, the market is classified into topical medications and oral medications. The topical segment is expected to register the highest CAGR of 3.9% during the forecast period. Moreover, the segment dominated in 2019, accounting for four-fifths of the market.

Based on type, the market is categorized into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne.

The global acne medication market is analyzed across several regions such as Asia-Pacific, LAMEA, Europe, and North America. The market across Asia-Pacific is expected to portray the highest CAGR of 4.9% during the forecast period. However, the market across North America held the largest share in 2019, accounting for nearly half of the market.

Get the Full Report: https://www.alliedmarketresearch.com/acne-medication-market

Contact
nikhil algoudar
***@gmail.com
End
Source:AMR
Email:***@gmail.com
Tags:Share
Industry:Health
Location:Pune - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Anant pvt ltd PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share